IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,681,137 | -2.1% | 797,626 | +8.2% | 0.00% | 0.0% |
| Q2 2023 | $7,844,638 | -29.4% | 737,278 | -30.2% | 0.00% | 0.0% |
| Q1 2023 | $11,110,266 | -3.9% | 1,056,109 | +13.2% | 0.00% | 0.0% |
| Q4 2022 | $11,561,245 | +71.7% | 933,111 | +43.5% | 0.00% | 0.0% |
| Q3 2022 | $6,734,000 | +47.9% | 650,100 | +64.6% | 0.00% | 0.0% |
| Q2 2022 | $4,554,000 | -39.6% | 394,970 | -34.1% | 0.00% | 0.0% |
| Q1 2022 | $7,539,000 | +4.4% | 599,334 | -3.2% | 0.00% | 0.0% |
| Q4 2021 | $7,223,000 | +37.2% | 619,380 | +53.6% | 0.00% | 0.0% |
| Q3 2021 | $5,265,000 | +5.9% | 403,220 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $4,973,000 | +6.0% | 386,398 | -7.9% | 0.00% | 0.0% |
| Q1 2021 | $4,690,000 | +67.7% | 419,548 | +70.9% | 0.00% | – |
| Q4 2020 | $2,797,000 | -14.4% | 245,528 | -32.4% | 0.00% | – |
| Q3 2020 | $3,267,000 | -43.6% | 363,176 | -35.3% | 0.00% | -100.0% |
| Q2 2020 | $5,795,000 | +81.3% | 561,589 | +77.3% | 0.00% | 0.0% |
| Q1 2020 | $3,196,000 | -40.5% | 316,777 | -21.5% | 0.00% | 0.0% |
| Q4 2019 | $5,375,000 | -15.4% | 403,785 | -45.4% | 0.00% | 0.0% |
| Q3 2019 | $6,352,000 | +0.6% | 739,872 | +28.2% | 0.00% | 0.0% |
| Q2 2019 | $6,311,000 | +87.1% | 576,924 | +131.5% | 0.00% | 0.0% |
| Q1 2019 | $3,373,000 | +30.6% | 249,258 | -0.0% | 0.00% | – |
| Q4 2018 | $2,583,000 | -20.2% | 249,277 | +42.2% | 0.00% | – |
| Q3 2018 | $3,236,000 | -57.1% | 175,244 | -55.6% | 0.00% | -100.0% |
| Q2 2018 | $7,542,000 | +10.5% | 394,409 | -10.8% | 0.00% | 0.0% |
| Q1 2018 | $6,824,000 | +39.4% | 442,230 | +35.4% | 0.00% | 0.0% |
| Q4 2017 | $4,894,000 | -3.9% | 326,542 | +1.1% | 0.00% | 0.0% |
| Q3 2017 | $5,094,000 | +7.6% | 323,033 | +28.8% | 0.00% | 0.0% |
| Q2 2017 | $4,733,000 | +73.9% | 250,726 | +57.1% | 0.00% | 0.0% |
| Q1 2017 | $2,722,000 | +242.0% | 159,585 | +206.5% | 0.00% | – |
| Q4 2016 | $796,000 | -70.5% | 52,060 | -69.3% | 0.00% | -100.0% |
| Q3 2016 | $2,697,000 | +111.2% | 169,804 | +74.0% | 0.00% | – |
| Q2 2016 | $1,277,000 | -8.3% | 97,600 | -23.3% | 0.00% | – |
| Q1 2016 | $1,392,000 | -37.3% | 127,284 | -33.5% | 0.00% | -100.0% |
| Q4 2015 | $2,219,000 | +10.2% | 191,461 | -0.9% | 0.00% | 0.0% |
| Q3 2015 | $2,014,000 | -29.3% | 193,282 | -18.2% | 0.00% | 0.0% |
| Q2 2015 | $2,850,000 | +1112.8% | 236,325 | +1509.5% | 0.00% | – |
| Q1 2015 | $235,000 | +4.9% | 14,683 | +0.6% | 0.00% | – |
| Q4 2014 | $224,000 | +16.1% | 14,591 | -2.4% | 0.00% | – |
| Q3 2014 | $193,000 | -44.1% | 14,951 | -33.3% | 0.00% | – |
| Q2 2014 | $345,000 | -35.2% | 22,410 | -48.3% | 0.00% | – |
| Q1 2014 | $532,000 | -19.0% | 43,322 | -23.5% | 0.00% | – |
| Q4 2013 | $657,000 | +17.1% | 56,598 | +19.5% | 0.00% | – |
| Q3 2013 | $561,000 | -14.0% | 47,376 | -27.8% | 0.00% | – |
| Q2 2013 | $652,000 | – | 65,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |